Auteurs
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Auteurs » - entrée « Tomonori Ishii »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Tomonori Hayashi < Tomonori Ishii < Tomonori Kobayakawa  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000093 (2020) Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonori Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon]Response to: 'Some concerns from Turkey' by Bilgin et al.
000124 (2020) Yoshikazu Nakaoka ; Mitsuaki Isobe ; Yoshiya Tanaka ; Tomonori Ishii ; Seido Ooka ; Hiroaki Niiro [Japon] ; Naoto Tamura ; Shogo Banno ; Hajime Yoshifuji [Japon] ; Yasushi Sakata ; Atsushi Kawakami ; Tatsuya Atsumi ; Shunsuke Furuta ; Hitoshi Kohsaka ; Katsuya Suzuki ; Ryoki Hara ; Yasuhiro Maejima ; Hiroshi Tsukamoto ; Yoshinari Takasaki ; Katsuhisa Yamashita ; Norihiro Okada ; Shinji Yamakido ; Syuji Takei ; Shumpei Yokota [Japon] ; Norihiro Nishimoto [Japon]Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.
000196 (2020) Masaaki Yoshida [Japon] ; Takehiro Hariya [Japon] ; Shunji Yokokura [Japon] ; Wataru Kobayashi [Japon] ; Ryu Watanabe [Japon] ; Tomonori Ishii [Japon] ; Toru Nakazawa [Japon]Concomitant herpes simplex keratitis and autoimmune-associated ulcerative keratitis in rheumatoid arthritis patients.
000362 (2019) Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonori Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon]Response to: 'Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment' by Lee.
000371 (2019) Tomoyuki Mutoh [Japon] ; Tomonori Ishii [Japon] ; Tsuyoshi Shirai [Japon] ; Kanae Akita [Japon] ; Yukiko Kamogawa [Japon] ; Yoko Fujita [Japon] ; Hiroko Sato [Japon] ; Yuko Shirota [Japon] ; Hiroshi Fujii [Japon] ; Hideo Harigae [Japon]Refractory Takayasu arteritis successfully treated with rituximab: case-based review.
000424 (2019) Atsushi Ogata [Japon] ; Yoshiya Tanaka [Japon] ; Tomonori Ishii [Japon] ; Motohide Kaneko [Japon] ; Hiroko Miwa [Japon] ; Shino Ohsawa [Japon] ; Reiji Yamakawa [Japon]Long-term safety and efficacy of weekly subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis who had an inadequate response to subcutaneous tocilizumab every other week: Results from the open-label extension of the SHINOBI study.
000844 (2018) Yoshikazu Nakaoka [Japon] ; Mitsuaki Isobe [Japon] ; Syuji Takei [Japon] ; Yoshiya Tanaka [Japon] ; Tomonori Ishii [Japon] ; Shumpei Yokota [Japon] ; Akira Nomura [Japon] ; Seitaro Yoshida [Japon] ; Norihiro Nishimoto [Japon]Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).
000930 (2018) Atsushi Ogata [Japon] ; Yoshiya Tanaka [Japon] ; Tomonori Ishii [Japon] ; Motohide Kaneko [Japon] ; Hiroko Miwa [Japon] ; Shino Ohsawa [Japon]A randomized, double-blind, parallel-group, phase III study of shortening the dosing interval of subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis and an inadequate response to subcutaneous tocilizumab every other week: Results of the 12-week double-blind period.
000F07 (2016) Yasuhiko Hirabayashi [Japon] ; Yasuhiko Munakata [Japon] ; Masayuki Miyata [Japon] ; Yukitomo Urata [Japon] ; Koichi Saito [Japon] ; Hiroshi Okuno [Japon] ; Masaaki Yoshida [Japon] ; Takao Kodera [Japon] ; Ryu Watanabe [Japon] ; Seiya Miyamoto [Japon] ; Tomonori Ishii [Japon] ; Shigeshi Nakazawa [Japon] ; Hiromitsu Takemori [Japon] ; Takanobu Ando [Japon] ; Takashi Kanno [Japon] ; Masataka Komagamine [Japon] ; Ichiro Kato [Japon] ; Yuichi Takahashi [Japon] ; Atsushi Komatsuda [Japon] ; Kojiro Endo [Japon] ; Chihiro Murai [Japon] ; Yuya Takakubo [Japon] ; Takao Miura [Japon] ; Yukio Sato [Japon] ; Kazunobu Ichikawa [Japon] ; Tsuneo Konta [Japon] ; Noriyuki Chiba [Japon] ; Tai Muryoi [Japon] ; Hiroko Kobayashi [Japon] ; Hiroshi Fujii [Japon] ; Yukio Sekiguchi [Japon] ; Akira Hatakeyama [Japon] ; Ken Ogura [Japon] ; Hirotake Sakuraba [Japon] ; Tomoyuki Asano [Japon] ; Hiroshi Kanazawa [Japon] ; Eiji Suzuki [Japon] ; Satoshi Takasaki [Japon] ; Kenichi Asakura [Japon] ; Kota Sugisaki [Japon] ; Yoko Suzuki [Japon] ; Michiaki Takagi [Japon] ; Takahiro Nakayama ; Hiroshi Watanabe [Japon] ; Keiki Miura [Japon] ; Yu Mori [Japon]Clinical and structural remission rates increased annually and radiographic progression was continuously inhibited during a 3-year administration of tocilizumab in patients with rheumatoid arthritis: A multi-center, prospective cohort study by the Michinoku Tocilizumab Study Group.
001073 (2015) Atsushi Ogata ; Koichi Amano ; Hiroaki Dobashi ; Masayuki Inoo ; Tomonori Ishii ; Tsuyoshi Kasama ; Shinichi Kawai ; Atsushi Kawakami ; Tatsuya Koike ; Hisaaki Miyahara ; Toshiaki Miyamoto ; Yasuhiko Munakata ; Akira Murasawa ; Norihiro Nishimoto ; Noriyoshi Ogawa ; Tomohiro Ojima ; Hajime Sano ; Kenrin Shi ; Eisuke Shono ; Eiichi Suematsu ; Hiroki Takahashi ; Yoshiya Tanaka ; Hiroshi Tsukamoto ; Akira NomuraLongterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study.
001295 (2014) Norihiro Nishimoto [Japon] ; Koichi Amano ; Yasuhiko Hirabayashi ; Takahiko Horiuchi ; Tomonori Ishii ; Mitsuhiro Iwahashi ; Masahiro Iwamoto ; Hitoshi Kohsaka ; Masakazu Kondo ; Tsukasa Matsubara ; Toshihide Mimura ; Hisaaki Miyahara ; Shuji Ohta ; Yukihiko Saeki ; Kazuyoshi Saito ; Hajime Sano ; Kiyoshi Takasugi ; Tsutomu Takeuchi ; Shigeto Tohma ; Tomomi Tsuru ; Yukitaka Ueki ; Jiro Yamana ; Jun Hashimoto ; Takaji Matsutani ; Miho Murakami ; Nobuhiro TakagiRetreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study.
001380 (2014) Norihiro Nishimoto [Japon] ; Koichi Amano ; Yasuhiko Hirabayashi ; Takahiko Horiuchi ; Tomonori Ishii ; Mitsuhiro Iwahashi ; Masahiro Iwamoto ; Hitoshi Kohsaka ; Masakazu Kondo ; Tsukasa Matsubara ; Toshihide Mimura ; Hisaaki Miyahara ; Shuji Ohta ; Yukihiko Saeki ; Kazuyoshi Saito ; Hajime Sano ; Kiyoshi Takasugi ; Tsutomu Takeuchi ; Shigeto Tohma ; Tomomi Tsuru ; Yukitaka Ueki ; Jiro Yamana ; Jun Hashimoto ; Takaji Matsutani ; Miho Murakami ; Nobuhiro TakagiDrug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study.
001382 (2014) Ryu Watanabe [Japon] ; Yasuhiko Hirabayashi ; Hiroshi Okuno ; Tomonori Ishii ; Hideo HarigaeDramatic radiographic repair by tocilizumab in a very elderly patient with rheumatoid arthritis.
001495 (2013) Yasuhiko Hirabayashi [Japon] ; Tomonori IshiiThe DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab.
001A46 (2010) Yasuhiko Hirabayashi [Japon] ; Tomonori Ishii ; Hideo HarigaeClinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "Tomonori Ishii" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "Tomonori Ishii" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Tomonori Ishii
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021